SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-004414
Accepted
2021-11-22 00:15:09
Documents
1
Effectiveness Date
2021-11-19
Registration Form
POS AM
Reference AccNo
0001104659-21-140539

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 609
  Complete submission text file 9999999995-21-004414.txt   1693
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-224983 | Film No.: 211430035
SIC: 2834 Pharmaceutical Preparations